US WorldMeds
Making a Difference, Patient by Patient
Louisville, United States · $30.0M raised
- Headquarters
- Louisville
- Website
- usworldmeds.com
- Total Funding
- $30.0M
- Last Round
- $30.0M Venture RoundApr 2018
- Rounds
- 1
About
US WorldMeds is a privately held specialty pharmaceutical company that licenses, develops, and delivers medicines for patients with rare and challenging conditions, including high-risk neuroblastoma, malignant hyperthermia, and synovial sarcoma. The company's mission is to develop, license, and market meaningful and accessible healthcare products that improve lives and result in a thriving community of patients, employees, and shareholders. US WorldMeds is headquartered in Louisville, Kentucky, and has announced FDA approvals including TECELRA (afamitresgene autoleucel) and IWILFIN (eflornithine) for pediatric cancer treatment.
Summary
US WorldMeds is a Drug Discovery company based in Louisville, United States. It has raised $30.0M in total across 1 round, most recently a $30.0M Venture Round round in Apr 2018.
Funding History
Apr 2018
Similar Companies
The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/us-worldmeds"><img src="https://indexed.vc/api/badge/company/us-worldmeds" alt="US WorldMeds on Indexed.vc" width="260" height="76" /></a>